AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: BALFOUR JA FAULDS D
Citation: Ja. Balfour et D. Faulds, REPAGLINIDE, Drugs & aging, 13(2), 1998, pp. 173-180

Authors: GOA KL BALFOUR JA
Citation: Kl. Goa et Ja. Balfour, RISEDRONATE, Drugs & aging, 13(1), 1998, pp. 83-91

Authors: BALFOUR JA GOA KL
Citation: Ja. Balfour et Kl. Goa, RALOXIFENE, Drugs & aging, 12(4), 1998, pp. 335-341

Authors: ADKINS JC BALFOUR JA
Citation: Jc. Adkins et Ja. Balfour, BRIMONIDINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICALPOTENTIAL IN THE MANAGEMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION, Drugs & aging, 12(3), 1998, pp. 225-241

Authors: LANGTRY HD BALFOUR JA
Citation: Hd. Langtry et Ja. Balfour, AZITHROMYCIN - A REVIEW OF ITS USE IN PEDIATRIC, Drugs, 56(2), 1998, pp. 273-297

Authors: HILLS CJ WINTER SA BALFOUR JA
Citation: Cj. Hills et al., TOLTERODINE, Drugs, 55(6), 1998, pp. 813-820

Authors: COUKELL AJ BALFOUR JA
Citation: Aj. Coukell et Ja. Balfour, LEVONORGESTREL SUBDERMAL IMPLANTS - A REVIEW OF CONTRACEPTIVE EFFICACY AND ACCEPTABILITY, Drugs, 55(6), 1998, pp. 861-887

Authors: MCCLELLAN KJ BALFOUR JA
Citation: Kj. Mcclellan et Ja. Balfour, EPROSARTAN, Drugs, 55(5), 1998, pp. 713-718

Authors: LANGTRY HD BALFOUR JA
Citation: Hd. Langtry et Ja. Balfour, GLIMEPIRIDE - A REVIEW OF ITS USE IN THE MANAGEMENT OF TYPE-2 DIABETES-MELLITUS, Drugs, 55(4), 1998, pp. 563-584

Authors: WAGSTAFF AJ BALFOUR JA
Citation: Aj. Wagstaff et Ja. Balfour, COMBINATION HEPATITIS-A HEPATITIS-B VACCINE, Biodrugs, 8(3), 1997, pp. 235-239

Authors: LEA AP BALFOUR JA
Citation: Ap. Lea et Ja. Balfour, VIROSOMAL HEPATITIS-A VACCINE (STRAIN RG-SB) - A PRELIMINARY REVIEW OF ITS IMMUNOGENICITY, PROTECTIVE EFFICACY AND TOLERABILITY IN AT-RISK POPULATIONS, Biodrugs, 7(3), 1997, pp. 232-248

Authors: BALFOUR JA BENFIELD P
Citation: Ja. Balfour et P. Benfield, RIMEXOLONE, Biodrugs, 7(2), 1997, pp. 158-163

Authors: HARIA M BALFOUR JA
Citation: M. Haria et Ja. Balfour, LEVETIRACETAM, CNS DRUGS, 7(2), 1997, pp. 159-164

Authors: FOSTER RH BALFOUR JA
Citation: Rh. Foster et Ja. Balfour, ESTRADIOL AND DYDROGESTERONE - A REVIEW OF THEIR COMBINED USE AS HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN, Drugs & aging, 11(4), 1997, pp. 309-332

Authors: BALFOUR JA WILDE MI
Citation: Ja. Balfour et Mi. Wilde, DORZOLAMIDE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF GLAUCOMA AND OCULAR HYPERTENSION, Drugs & aging, 10(5), 1997, pp. 384-403

Authors: PETERS DC BALFOUR JA
Citation: Dc. Peters et Ja. Balfour, TACALCITOL, Drugs, 54(2), 1997, pp. 265-271

Authors: BALFOUR JA GOA KL
Citation: Ja. Balfour et Kl. Goa, DOLASETRON - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF NAUSEA AND VOMITING INDUCED BY CHEMOTHERAPY, RADIOTHERAPY OR SURGERY, Drugs, 54(2), 1997, pp. 273-298

Authors: WAGSTAFF AJ BALFOUR JA
Citation: Aj. Wagstaff et Ja. Balfour, GREPAFLOXACIN, Drugs, 53(5), 1997, pp. 817-824

Authors: PATEL SS BALFOUR JA BRYSON HM
Citation: Ss. Patel et al., FOSFOMYCIN TROMETHAMINE - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY AS A SINGLE-DOSE ORALTREATMENT FOR ACUTE UNCOMPLICATED LOWER URINARY-TRACT INFECTIONS, Drugs, 53(4), 1997, pp. 637-656

Authors: BALFOUR JA BENFIELD P
Citation: Ja. Balfour et P. Benfield, CEFPODOXIME PROXETIL - AN APPRAISAL OF ITS USE IN ANTIBACTERIAL COST-CONTAINMENT PROGRAMS, AS STEPDOWN AND ABBREVIATED THERAPY IN RESPIRATORY-TRACT INFECTIONS, PharmacoEconomics, 10(2), 1996, pp. 164-178

Authors: LEA AP BRYSON HM BALFOUR JA
Citation: Ap. Lea et al., POTENTIALLY SERIOUS ADVERSE EVENTS SUCH AS PRIAPISM (GREATER-THAN-6 HOURS DURATION) AND FIBROSIS OCCURRED IN 0.4 AND 8-PERCENT OF PATIENTS (VOL 8, PG 57, 1996), Drugs & aging, 8(5), 1996, pp. 357-357

Authors: LEA AP BRYSON HM BALFOUR JA
Citation: Ap. Lea et al., INTRACAVERNOUS ALPROSTADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN ERECTILE DYSFUNCTION, Drugs & aging, 8(1), 1996, pp. 56-74

Authors: PERRY CM BALFOUR JA
Citation: Cm. Perry et Ja. Balfour, DIDANOSINE - AN UPDATE ON ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HIV DISEASE, Drugs, 52(6), 1996, pp. 928-962

Authors: GOA KL BALFOUR JA ZUANETTI G
Citation: Kl. Goa et al., LISINOPRIL - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN THE EARLY MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION, Drugs, 52(4), 1996, pp. 564-588

Authors: DAVIS R MARKHAM A BALFOUR JA
Citation: R. Davis et al., CIPROFLOXACIN - AN UPDATED REVIEW OF ITS PHARMACOLOGY, THERAPEUTIC EFFICACY AND TOLERABILITY, Drugs, 51(6), 1996, pp. 1019-1074
Risultati: 1-25 | 26-40